The global Nitinol Tipless Stone Extractor market is dominated by North America, which holds a 40% value share, driven by advanced urology infrastructure, high adoption of minimally invasive procedures, and robust R&D investments. The region benefits from strong healthcare policies and a mature medical device ecosystem, ensuring sustained demand. Europe follows with a 30% share, supported by favorable reimbursement frameworks, aging demographics, and a focus on procedural efficiency. Asia Pacific, with a 20% value, is the fastest-growing region, fueled by rising healthcare investments, urbanization, and increasing awareness of urological treatments.